학술논문

Preoperative nasopharyngeal swab testing and postoperative pulmonary complications in patients undergoing elective surgery during the SARS-CoV-2 pandemic
Document Type
article
Author
Glasbey, James COmar, OmarNepogodiev, DmitriMinaya-Bravo, AnaBankhead-Kendall, Brittany KayFiore, MarcoFutaba, KaoriGabre-Kidan, AlodiaGujjuri, Rohan RIsik, ArdaKaafarani, Haytham MAKamarajah, Sivesh KLi, ElizabethLöffler, Markus WMcLean, Kenneth AOutani, OumaimaNtirenganya, FaustinSatoi, SoheiShaw, RichardSimoes, Joana FFStewart, Grant DTabiri, StephenTrout, Isobel MBhangu, Aneel ASiaw-Acheampong, KwabenaBenson, Ruth ABywater, EdwardChaudhry, DaoudDawson, Brett EEvans, Jonathan PHeritage, EmilyJones, Conor SKhatri, ChetanKhaw, Rachel AKeatley, James MKnight, AndrewLawday, SamuelMann, Harvinder SMarson, Ella JMckay, Siobhan CMills, Emily CPellino, GianlucaPicciochi, MariaTaylor, Elliott HTiwari, AbhinavVenn, Mary LWilkin, Richard JWBhangu, AneelSmart, Neil JGallo, GaetanoMoug, SusanPata, FrancescoPockney, PeterDi Saverio, SalomoneVallance, AbigailVimalchandran, DaleGriffiths, Ewen AEvans, Richard PTTownend, PhilipRoberts, KeithMcKay, SiobhanIsaac, JohnEdwards, JohnCoonar, Aman SMarchbank, AdrianCaruana, Edward JLayton, Georgia RPatel, AkshayBrunelli, AlessandroFord, SamuelDesai, AnantGronchi, AlessandroAlmond, MaxTirotta, FabioDumitra, SinzianaKolias, AngelosPrice, Stephen JFountain, Daniel MJenkinson, Michael DHutchinson, PeterMarcus, Hani JPiper, Rory JLippa, Laura
Source
British Journal of Surgery. 108(1)
Subject
Clinical Research
Emerging Infectious Diseases
Vaccine Related
Cancer
Patient Safety
Biodefense
Prevention
Lung
6.4 Surgery
Evaluation of treatments and therapeutic interventions
Good Health and Well Being
Aged
Aged
80 and over
COVID-19
COVID-19 Nucleic Acid Testing
Elective Surgical Procedures
Female
Humans
Lung Diseases
Male
Middle Aged
Nasopharynx
Neoplasms
Pandemics
Postoperative Complications
Risk Assessment
SARS-CoV-2
COVIDSurg Collaborative
Medical and Health Sciences
Surgery
Language
Abstract
BackgroundSurgical services are preparing to scale up in areas affected by COVID-19. This study aimed to evaluate the association between preoperative SARS-CoV-2 testing and postoperative pulmonary complications in patients undergoing elective cancer surgery.MethodsThis international cohort study included adult patients undergoing elective surgery for cancer in areas affected by SARS-CoV-2 up to 19 April 2020. Patients suspected of SARS-CoV-2 infection before operation were excluded. The primary outcome measure was postoperative pulmonary complications at 30 days after surgery. Preoperative testing strategies were adjusted for confounding using mixed-effects models.ResultsOf 8784 patients (432 hospitals, 53 countries), 2303 patients (26.2 per cent) underwent preoperative testing: 1458 (16.6 per cent) had a swab test, 521 (5.9 per cent) CT only, and 324 (3.7 per cent) swab and CT. Pulmonary complications occurred in 3.9 per cent, whereas SARS-CoV-2 infection was confirmed in 2.6 per cent. After risk adjustment, having at least one negative preoperative nasopharyngeal swab test (adjusted odds ratio 0.68, 95 per cent confidence interval 0.68 to 0.98; P = 0.040) was associated with a lower rate of pulmonary complications. Swab testing was beneficial before major surgery and in areas with a high 14-day SARS-CoV-2 case notification rate, but not before minor surgery or in low-risk areas. To prevent one pulmonary complication, the number needed to swab test before major or minor surgery was 18 and 48 respectively in high-risk areas, and 73 and 387 in low-risk areas.ConclusionPreoperative nasopharyngeal swab testing was beneficial before major surgery and in high SARS-CoV-2 risk areas. There was no proven benefit of swab testing before minor surgery in low-risk areas.